Singapore markets closed
  • Straits Times Index

    3,077.69
    -22.61 (-0.73%)
     
  • S&P 500

    4,372.13
    -70.98 (-1.60%)
     
  • Dow

    34,464.77
    -404.60 (-1.16%)
     
  • Nasdaq

    14,630.44
    -339.53 (-2.27%)
     
  • BTC-USD

    41,567.96
    -2,459.29 (-5.59%)
     
  • CMC Crypto 200

    1,027.97
    -29.18 (-2.76%)
     
  • FTSE 100

    7,018.85
    -44.55 (-0.63%)
     
  • Gold

    1,738.10
    -13.90 (-0.79%)
     
  • Crude Oil

    75.40
    -0.05 (-0.07%)
     
  • 10-Yr Bond

    1.5410
    +0.0570 (+3.84%)
     
  • Nikkei

    30,183.96
    -56.10 (-0.19%)
     
  • Hang Seng

    24,500.39
    +291.61 (+1.20%)
     
  • FTSE Bursa Malaysia

    1,546.82
    +13.77 (+0.90%)
     
  • Jakarta Composite Index

    6,113.11
    -9.38 (-0.15%)
     
  • PSE Index

    6,885.36
    -70.90 (-1.02%)
     

Europe buys 220,000 doses of Vir, GSK's experimental COVID-19 treatment

·1-min read
Europe buys 220,000 doses of Vir, GSK's experimental COVID-19 treatment
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Shares of Vir Biotechnology Inc. gained 1.9% in premarket trading on Wednesday after the company and GlaxoSmithKline said the European Commission purchased 220,00 doses of their investigational COVID-19 antibody treatment. The therapy is a single-dose monoclonal antibody that is being tested as a treatment to ward off severe disease in some high-risk COVID-19 patients. The European Medicines Agency is currently reviewing the companies' application for sotrovimab. (Sotrovimab received emergency a

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting